# Combined Sertraline and Ketoprofen Administration in Major Depressive Disorder

> **NCT03514810** · PHASE1 · COMPLETED · sponsor: **Kufa University** · enrollment: 28 (actual)

## Conditions studied

- Major Depressive Disorder

## Interventions

- **COMBINATION_PRODUCT:** Combined Sertraline & Ketoprofen
- **OTHER:** Interleukins in MDD after treatment

## Key facts

- **NCT ID:** NCT03514810
- **Lead sponsor:** Kufa University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-01-10
- **Primary completion:** 2017-09-10
- **Final completion:** 2017-12-31
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2018-05-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03514810

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03514810, "Combined Sertraline and Ketoprofen Administration in Major Depressive Disorder". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03514810. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*